0001127602-18-012824.txt : 20180327 0001127602-18-012824.hdr.sgml : 20180327 20180327090315 ACCESSION NUMBER: 0001127602-18-012824 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180323 FILED AS OF DATE: 20180327 DATE AS OF CHANGE: 20180327 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KING DAVID P CENTRAL INDEX KEY: 0001275654 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 18714187 MAIL ADDRESS: STREET 1: 531 SOUTH SPRING STREET CITY: BURLINGTON STATE: NC ZIP: 27215 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 133757370 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2018-03-23 0000920148 LABORATORY CORP OF AMERICA HOLDINGS LH 0001275654 KING DAVID P 531 SOUTH SPRING STREET BURLINGTON NC 27215 1 1 President & CEO Common Stock 2018-03-23 4 M 0 49967 84.86 A 231202.3298 D Common Stock 2018-03-23 4 S 0 1689 163.5805 D 229513.3298 D Common Stock 2018-03-23 4 S 0 36265 164.5508 D 193248.3298 D Common Stock 2018-03-23 4 S 0 10313 165.3891 D 182935.3298 D Common Stock 2018-03-23 4 S 0 1700 166.3752 D 181235.3298 D Common Stock 27811 I By grantor retained annuity trust Common Stock 47357 I By grantor retained annuity trust Non-qualified Stock Options 84.86 2018-03-23 4 M 0 49967 0 D 2013-05-24 2022-05-23 Common Stock 49967 99933 D Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. The price of $163.5805 per share represents a weighted average of sales prices ranging from $162.96 to $163.865 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. The price of $164.5508 per share represents a weighted average of sales prices ranging from $163.995 to $164.98 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. The price of $165.3891 per share represents a weighted average of sales prices ranging from $164.99 to $165.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. The price of $166.3752 per share represents a weighted average of sales prices ranging from $166.089 to $166.80 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. The option vested in three equal annual installments beginning on 05/24/2013 and is now fully exercisable. /s/ F. Samuel Eberts III, Attorney-in-Fact for David P. King 2018-03-27